StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) KPIs and segments

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive XORTX Therapeutics's business

Coming soon

This tab will track the numbers specific to XORTX Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?